Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Eatedal H. Abdel Aal"'
Publikováno v:
ARKIVOC, Vol 2008, Iss 10, Pp 127-134 (2008)
Externí odkaz:
https://doaj.org/article/5a0608ca27164ad48acd8f0ead5f557b
Autor:
Khalid A. Agha, Nader E. Abo-Dya, Abdul Rashid Issahaku, Clement Agoni, Mahmoud E. S. Soliman, Eatedal H. Abdel-Aal, Zakaria K. Abdel-Samii, Tarek S. Ibrahim
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 37, Iss 1, Pp 1241-1256 (2022)
An efficient method for synthesising NMDAR co-agonist Sunifiram (DM235), in addition to Sunifram-carbamate and anthranilamide hybrids, has been developed in high yields via protecting group-free stepwise unsymmetric diacylation of piperazine using N-
Externí odkaz:
https://doaj.org/article/4e635989cfea448eab1877e1019864be
Autor:
Riham M. Bokhtia, Adel S. Girgis, Tarek S. Ibrahim, Fatma Rasslan, Eman S. Nossier, Reham F. Barghash, Rajeev Sakhuja, Eatedal H. Abdel-Aal, Siva S. Panda, Amany M. M. Al-Mahmoudy
Publikováno v:
Pharmaceuticals, Vol 15, Iss 2, p 191 (2022)
The development of new antibiotics to treat multidrug-resistant (MDR) bacteria or possess broad-spectrum activity is one of the challenging tasks. Unfortunately, there are not many new antibiotics in clinical trials. So, the molecular hybridization a
Externí odkaz:
https://doaj.org/article/710c2b076dac4c72b7f1d5e460164be3
Autor:
Zakaria K. Abdel-Sami, Nader E. Abo-Dya, Eatedal H. Abdel-Aal, Ahmed A. Al-Karmalawy, Rana T. Diab
Publikováno v:
New Journal of Chemistry. 45:21657-21669
The development of anticancer compounds targeting the colchicine-binding site of tubulin, termed colchicine-binding site inhibitors (CBSIs) is a promising research area for pharmaceutical companies and research institutes. A series of 3,5-disubstitut
Autor:
Rajeev Sakhuja, Walid Fayad, Eatedal H. Abdel-Aal, Adel S. Girgis, Hitesh H. Honkanadavar, Riham M. Bokhtia, Amany M.M. Al-Mahmoudy, Mona T. Kashef, Tarek S. Ibrahim, Riham F. George, Siva S. Panda
Publikováno v:
Medicinal Chemistry. 17:71-84
Background: Bacterial infections are considered as one of the major global health threats, so it is very essential to design and develop new antibacterial agents to overcome the drawbacks of existing antibacterial agents. Method: The aim of this work
Autor:
Girinath G. Pillai, Lara Gigli, Eatedal H. Abdel-Aal, Amany M.M. Al-Mahmoudy, Tarek S. Ibrahim, Siva S. Panda, ElSayed M. Shalaby, Riham M. Bokhtia, Adel S. Girgis
Publikováno v:
ChemistrySelect. 5:13963-13968
Autor:
Nader E. Abo-Dya, Zakaria K. Abdel-Samii, Khalid A. Agha, Tarek S. Ibrahim, Eatedal H. Abdel-Aal
Publikováno v:
Monatshefte für Chemie - Chemical Monthly. 151:589-598
An efficient green route for monoacylation of aromatic diamines, namely o-phenylenediamine and p-phenylenediamine and aliphatic diamines ethylenediamine and piperazine using N-acylbenzotriazoles (NABs) in n-butanol was developed. The new protocol doe
Autor:
Nader E. Abo-Dya, Eatedal H. Abdel-Aal, Tarek S. Ibrahim, Zakaria K. Abdel-Samii, Khalid A. Agha, Nehal M. Elsherbiny, Mohamed El-Sherbiny
Publikováno v:
Bioorganic chemistry. 114
Cisplatin (CP) is an effective chemotherapeutic agent for treatment of various types of cancer, however efforts are needed to reduce its toxic side effect. Previous studies revealed promising effect of peptides in decreasing CP induced nephrotoxicity
Autor:
Mohamed A. Tantawy, Tarek S. Ibrahim, Eatedal H. Abdel-Aal, Ehab S. Taher, Nermine A. Osman, A. H. Hassan, Bahaa G.M. Youssif, Amany M.M. Al-Mahmoudy
Publikováno v:
Anti-cancer agents in medicinal chemistry. 22(5)
Background: Pyrimidine-5-carbonitrile has a broad spectrum of biological activities such as antiviral, antioxidant, and anticancer activities. Among similar compounds, monastrol is the most prominent cell-permeant inhibitor of mitosis; therefore, we
Autor:
Hisham A. Abbas, Moataz A. Shaldam, Zakaria K. Abdel-Samii, Eatedal H. Abdel-Aal, Amany M. Ghanim, Basant Mohamed
Publikováno v:
Archiv der Pharmazie. 353
In an attempt to counteract bacterial pathogenicity, a set of novel imidazolidine-2,4-dione and 2-thioxoimidazolidin-4-one derivatives was synthesized and evaluated as inhibitors of bacterial virulence. The new compounds were characterized and screen